Engineered immune cells take aim at Hard-to-Treat cancers

This study tests a new treatment for adults with certain cancers (pancreatic, kidney, breast, melanoma, or ovarian) that have a protein called CD70. Doctors take a sample of your blood, modify your white blood cells in a lab to recognize and attack CD70, and then give them back to you. The goal is to see if this gene therapy can safely shrink tumors. Participants will receive chemotherapy before the cell infusion and must take antibiotics for six months after.